ArticleJAC-antimicrobial resistance2025
Trends in antibiotic dispensing for children in Belgian ambulatory care: time series analysis before, during, and after the COVID-19 pandemic.
Article in JAC-antimicrobial resistance, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Impact of the COVID-19 Pandemic on the Outcomes of a Multifaceted Program on Antibiotic Prescribing in Primary Care Among Children Under Three Years of Age.Antibiotics (Basel, Switzerland) · 2026Article
- Trends in antibiotic dispensing for children in Belgian ambulatory care: time series analysis before, during, and after the COVID-19 pandemic.JAC-antimicrobial resistance · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The aim of this study is to analyse trends in paediatric antibiotic use in Belgian ambulatory care across three COVID-19 pandemic-related periods. Methods: We conducted a retrospective time series analysis using autoregressive integrated moving average modelling. The analysis is based on anonymized pharmacy dispensing data for antibiotics delivered to Belgian children aged 0-12 years, retrieved from Farmanet for the period from 2014 until 2023. The outcome measures were the number of packages, expenditures and DDDs. Outcomes were analysed for all antibiotics collectively and for subgroups based on patient characteristics, prescriber specialty, geographic region and antibiotic characteristics. Results: Antibiotic use among children in Belgian ambulatory care sharply declined during the COVID-19 pandemic (-42.7%), followed by a gradual return to pre-pandemic levels (+66.9%), which was primarily driven by prescriptions of antibiotics commonly used for respiratory tract infections. The initial reduction exceeded expected seasonal variations. The largest decreases during the pandemic and subsequent increases were observed among children aged 7-12 years, those with standard reimbursement, in prescriptions by general practitioners and in rural areas of Flanders and the Walloon region. Conclusions: The COVID-19 pandemic significantly disrupted paediatric antibiotic prescribing patterns in Belgian ambulatory care. These findings highlight the importance of sustained antimicrobial stewardship efforts, not only in routine healthcare settings but also during periods of altered care delivery.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.